Hi MasterSalix,
There are a couple of things wrong with your reasoning.
First, for the 20 or so years that John Q can goose the market with online trading, value per share has become almost meaningless, and has been since at least the mid 90s. Examine Amazon.com if you want an example ... very modest profits ... HUGE market cap ... lots of investor enthusiasm. Knee jerk means more than balance sheets and that has been true all these 20 years.
Second, if you read the thread, two things are important to this discussion. One is that Medite wanted to go public, and this was a cheap way for them to do so. The husband and wife team that own Medite are the only important pieces of this puzzle. This stock is now about what they want to do with their stock and if they are capable of increasing its value. They've shown good business sense in the past so I'm going to count on them to make my rather large count of shares actually worth something in the future. Next is that they are acquiring some extremely valuable patented products whose marketing has been completely bungled for years.
Cytocore couldn't sell water to a dehydrated man, but Medite seems to actually know how business gets done. If they sell the Collector product, which is a quantum leap advance over the Pap Smear, their sales and profits will blow the top off the chart. It's a mass market product ... something essentially needed once every year or two for every pre-menopausal woman in the world.
There isn't a doubt in my mind that if they start selling the Collector that this stock will substantially increase in value. It didn't start out a penny stock. It was well valued as a start-up with a patent ... it only fell to penny stock status because these guys were researchers, not salesmen.
